Skip to main content
Premium Trial:

Request an Annual Quote

BGI Bolsters Stock of Illumina Sequencers

NEW YORK (GenomeWeb News) – The Beijing Genomics Institute has purchased 12 new Genome Analyzers for use in its Hong Kong and Shenzhen research centers, the company said today.

BGI will use the new sequencing capacity to support its ongoing and planned programs, including the 1000 Genomes Project, the Chinese Cancer Genome project, the Tree of Life Project, and other agriculture, biomedical, and biofuel research programs.

Eight of the sequencers will be installed in BGI's Hong Kong facility and four will be used in studies at its Shenzhen labs. Financial terms of the purchase were not released.

BGI, which has seven branches in China, one in the US, and one in Europe, will now have a total of 29 of these next generation Illumina analyzers.

In addition to its research programs, BGI offers sequencing services to the international community.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.